Results acquired from scRNA-seq advocated for the presence of differential expression of KRT19 between KYSE-30 and parental esophageal cancer cells, thus suggesting that there is inherent paclitaxel resistance in esophageal cancer (56). The gene discussed is KRT19; the disease is esophageal cancer.